These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25257344)

  • 1. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008.
    Lafeuillade B; Eb F; Ounnoughene N; Petermann R; Daurat G; Huyghe G; Vo Mai MP; Caldani C; Rebibo D; Weinbreck P
    Transfusion; 2015 Mar; 55(3):636-46. PubMed ID: 25257344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007. Groupe de travail–validation des IBTT (Working group for validation of transfusion-transmitted bacterial infections)].
    Delbosc A; Lafeuillade B; Petermann R; Eb F; Ounnoughene N
    Transfus Clin Biol; 2011 Feb; 18(1):26-35. PubMed ID: 21310643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011-2020).
    Orru' S; Oberle D; Heiden M; Müller S; Krut O; Funk MB
    Transfus Med Hemother; 2023 Apr; 50(2):144-153. PubMed ID: 37066059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of bacterial risk: pathogen inactivation/detection of bacteria].
    Morel P; Naegelen C; Deschaseaux M; Bardiaux L
    Transfus Clin Biol; 2013 May; 20(2):109-14. PubMed ID: 23622837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of the bacterial risk of transfusion in France in 2013].
    Morel P; Deschaseaux M; Bertrand X; Naegelen C; Leconte des Floris MF; Bardiaux L
    Transfus Clin Biol; 2013 May; 20(2):174-81. PubMed ID: 23622838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.
    Benjamin RJ; Braschler T; Weingand T; Corash LM
    Transfusion; 2017 Dec; 57(12):2946-2957. PubMed ID: 28840603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-transmitted bacterial infection: risks, sources and interventions.
    Wagner SJ
    Vox Sang; 2004 Apr; 86(3):157-63. PubMed ID: 15078249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry.
    Zavizion B; Serebryanik D; Chapman J; Alford B; Purmal A
    Vox Sang; 2004 Oct; 87(3):143-9. PubMed ID: 15569065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of germs involved in septicemia].
    Idomir ME; Ticău O; Cocuz ME; Badea M; Taus N
    Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):53-7. PubMed ID: 16752754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
    Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
    Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections in pediatric patients.
    Babay HA; Twum-Danso K; Kambal AM; Al-Otaibi FE
    Saudi Med J; 2005 Oct; 26(10):1555-61. PubMed ID: 16228055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections.
    Richard P; Pouchol E; Sandid I; Aoustin L; Lefort C; Chartois AG; Baima A; Malard L; Bacquet C; Ferrera-Tourenc V; Gallian P; Laperche S; Bliem C; Morel P; Tiberghien P
    Vox Sang; 2024 Mar; 119(3):212-218. PubMed ID: 38152857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection.
    Robillard P; Delage G; Itaj NK; Goldman M
    Transfusion; 2011 Jul; 51(7):1405-11. PubMed ID: 21214581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antibiotic susceptibility pattern of bacterial isolates from blood culture in Tikur Anbassa Hospital, Addis Ababa, Ethiopia.
    Asrat D; Amanuel YW
    Ethiop Med J; 2001 Apr; 39(2):97-104. PubMed ID: 11501295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
    Bertrand X; Costa Y; Pina P
    Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological analysis of platelets and cases of septic reactions associated with transfusion of contaminated samples.
    Martini R; Horner R; Rodrigues Mde A; Kempfer CB; Tizotti MK; Ratzlaff V
    Transfus Apher Sci; 2012 Dec; 47(3):313-8. PubMed ID: 22842109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do leukoreduction filters passively reduce the transmission risk of human granulocytic anaplasmosis?
    Proctor MC; Leiby DA
    Transfusion; 2015 Jun; 55(6):1242-8. PubMed ID: 25556513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.